LU75403A1 - - Google Patents

Info

Publication number
LU75403A1
LU75403A1 LU75403A LU75403A LU75403A1 LU 75403 A1 LU75403 A1 LU 75403A1 LU 75403 A LU75403 A LU 75403A LU 75403 A LU75403 A LU 75403A LU 75403 A1 LU75403 A1 LU 75403A1
Authority
LU
Luxembourg
Application number
LU75403A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB30072/75A external-priority patent/GB1545213A/en
Application filed filed Critical
Publication of LU75403A1 publication Critical patent/LU75403A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018Esters of cycloaliphatic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
LU75403A 1975-07-17 1976-07-16 LU75403A1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB30072/75A GB1545213A (en) 1975-07-17 1975-07-17 Prostaglandin analogues
GB1865176 1976-05-06

Publications (1)

Publication Number Publication Date
LU75403A1 true LU75403A1 (xx) 1977-04-04

Family

ID=26253511

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75403A LU75403A1 (xx) 1975-07-17 1976-07-16

Country Status (10)

Country Link
US (1) US4087620A (xx)
JP (1) JPS5922699B2 (xx)
CA (1) CA1091662A (xx)
CH (1) CH616409A5 (xx)
DE (1) DE2631894C2 (xx)
DK (1) DK318876A (xx)
FR (1) FR2317916A1 (xx)
HU (1) HU176144B (xx)
LU (1) LU75403A1 (xx)
NL (1) NL7607800A (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1568371A (en) * 1975-12-03 1980-05-29 Allen & Hanburys Ltd Bicyclo(2,2,1)heptan-2-one-derivatives
GB1588196A (en) * 1977-06-14 1981-04-15 Ono Pharmaceutical Co Prostaglandin analogues
DE2834249A1 (de) * 1978-08-04 1980-02-28 Hoechst Ag Neue prostaglandinderivate in der delta 2-11-desoxy-pgf tief 2 bzw. pge tief 2 -reihe
US4312994A (en) * 1981-03-25 1982-01-26 G. D. Searle & Co. α Chain dienic prostanoic acid derivatives
US4983753A (en) * 1981-05-21 1991-01-08 Floyd Jr Middleton B Precursors and synthesis of di-(methyl)-16,16-(dimethyl)-11-alpha,15-alpha beta-dihydroxy-9-oxo-2,13-trans,trans-prostadienoates
US5166369A (en) * 1981-05-21 1992-11-24 American Cyanamid Company Precursors and synthesis of D1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
JPS6130554A (ja) * 1984-07-23 1986-02-12 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
CA2610692C (en) 2005-06-03 2014-11-25 Ono Pharmaceutical Co., Ltd. Ep2 agonists which may have an ep3 agonistic effect for regeneration and/or protection of nerves
EP3705472B1 (en) 2017-10-31 2023-06-21 AGC Inc. Method for producing prostaglandin derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034003A (en) * 1974-04-11 1977-07-05 Ono Pharmaceutical Co., Ltd. 15-Cycloalkyl-prostaglandins

Also Published As

Publication number Publication date
FR2317916B1 (xx) 1981-01-23
US4087620A (en) 1978-05-02
JPS5922699B2 (ja) 1984-05-28
HU176144B (en) 1980-12-28
NL7607800A (nl) 1977-01-19
CA1091662A (en) 1980-12-16
DE2631894C2 (de) 1986-01-23
FR2317916A1 (fr) 1977-02-11
CH616409A5 (xx) 1980-03-31
DK318876A (da) 1977-01-18
DE2631894A1 (de) 1977-02-10
JPS5227753A (en) 1977-03-02

Similar Documents

Publication Publication Date Title
JPS51100149A (xx)
FR2346330B1 (xx)
JPS5347176B2 (xx)
JPS522189U (xx)
JPS5442317Y2 (xx)
JPS5536912B2 (xx)
JPS5751686B2 (xx)
JPS51109652A (xx)
JPS5194730A (xx)
FR2298629B1 (xx)
JPS556308Y2 (xx)
JPS5755591B2 (xx)
JPS51155469U (xx)
JPS5278708U (xx)
JPS51107529U (xx)
CH593356A5 (xx)
AU481365A (xx)
CH580337A5 (xx)
CH587687A5 (xx)
CH594079A5 (xx)
BG26465A1 (xx)
CH594706A5 (xx)
BG22942A1 (xx)
BG22482A1 (xx)
BG23157A1 (xx)